This podcast episode discusses the potential impact of anti-obesity medications on the medtech industry. While anti-obesity drugs may reduce obesity rates, leading to lower sales of medical devices due to fewer obese patients, they can also increase life expectancy and demand for procedures that were previously inaccessible to obese individuals. Overall, the impact of anti-obesity drugs on the medtech industry is complex and multifaceted.